Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
In this podcast, Paul Y. Kwo, MD talks about his research that investigated different strategies for treating chronic hepatitis C virus (HCV), as well as why he believes the diagnosis of HVC and treatment...
In part 1 of this podcast series, Vincent Lo Re, MD, talks about the current knowledge gaps around hepatitis C virus screening, as well as how health care providers can implement better screening protocols...
In this podcast, Talia Segal and Michael Waxman, MD, MPH, talk about their research that investigated the demographics of patients with hepatitis C virus before and after the US Preventive Services Task...
In this podcast, Marc Ghany, MD, MHSc, discusses the recent publication of "Hepatitis C Guidance 2019 Update: AASLD‐IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection." He...
Jorge Herrera, MD director of the Section of Hepatology and professor of Internal Medicine at the University of South Alabama, discusses screening, referring, and managing patients with hepatitis C virus.
...
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
Sammy Saab, MD, MPH, from the Ronald Reagan UCLA Medical Center explains the potentially deadly consequences of hepatitis B reactivation in patients being treated for hepatitis C, and why screening for...
A new study has indicated that the transplantation of HCV-positive livers into HCV-negative individuals may be a viable option in the era of direct-acting antiviral therapy. Consultant360 discussed the...
